Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
(R)-Semixanthomegnin
150
CHF
CHF 150.00
In stock
BVT-0366-C500500 µgCHF 150.00
BVT-0366-M0011 mgCHF 250.00
Product Details | |
---|---|
Product Type | Chemical |
Properties | |
Formula |
C15H12O6 |
MW | 288.3 |
Source/Host Chemicals | Derivative of semivioxanthin from Penicillium citreo-viride. |
Purity Chemicals | ≥97% (HPLC) |
Appearance | Orange crystalline solid. |
Solubility | Soluble in chloroform or DMSO. Poorly soluble in methanol or water. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by BioViotica. |
InChi Key | YPJWDOQDLYENRC-ZCFIWIBFSA-N |
Smiles | COC1=CC(=O)C2=C(O)C3=C(C[C@@H](C)OC3=O)C=C2C1=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Keep cool and dry. |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Antibacterial mycotoxin derivative.
- Monomer (half) of the genotoxic mycotoxin xanthomegnin.
Product References
- Isolierung des Antibioticums semi-Vioxanthin aus Penicillium citreo-viride und Synthese des Xanthomegnins: A. Zeeck, et al.; Chem. Ber. 112, 957 (1979)
- Toxicity, mutagenicity and tetragenicity of Brevianamide, Viomellein and Xanthomegnin; secondary metabolites of Penicillium viridicatum: A.J. Delucca, et al.; J. Food Safety 4, 165 (1982)
- Total synthesis of (R)-semixanthomegnin and the x-ray crystal structure of (±)-7-chloro-10-methoxy-3-methyl-3,4-dihydro-1H-naphtho[2,3-c]pyran-1,6,9-trione: A.S. Cotterill, et al.; Aust. J. Chem. 56, 49 (2003)
- Synthesis of pyran and pyranone natural products: Christopher D. Donner, et al.; Molecules 9, 498 (2004)